"THE SPIRITUALIST" Brings you Psychic Gossip from Hollywierd

 

Martin Shkreli, 32, founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim which is used for treating life-threatening parasitic infections - for $55million. He raised the price of the drug from $13.50 per tablet to $750 per tablet. Since the announcement, people across social media have criticized the price increase, but Shkreli has backed the decision, saying that his company 'need to turn a profit on the drug'.